So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye – Nasdaq
|
So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye
Nasdaq Kite Pharma is a clinical-stage developer of chimeric antigen receptor (CAR) T-cell therapies. CAR T-cells are a type of immunotherapy in which a patient's T cells are extracted from their blood and modified in a lab to produce receptors on their … |
